The creation of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, requires a complex multi-step organic process. Initial routes focused on peptide fragment coupling, utilizing solid-phase creation methodologies to build the long protein sequence. Subsequent investigation has explored different approaches, including enzymat